Home Supplements How We Rate Blog
Vinpocetine

Vinpocetine

Research reviewed: Up until 03/2026

Vinpocetine is a dietary supplement with 5 published peer-reviewed studies involving 520 participants, researched for Cerebral Blood Flow & Neuroprotection, Cognitive Function & Memory, Safety & Tolerability.

5
Studies
520
Participants
2008–2020
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Cerebral Blood Flow & Neuroprotection

Moderate
2 studies 2 of 2 positive 0 participants

Cognitive Function & Memory

Moderate
2 studies 0 of 2 positive 0 participants

Safety & Tolerability

Moderate
1 study 0 of 1 positive 0 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

2/5
Randomised
0/5
Double-Blind
0/5
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2016)
0
Study 2 (2008)
0
Study 1 (2020)
0
Study 2 (2018)
0
Study 1 (2017)
0

Research Timeline

When the studies were published

1
2008
1
2016
1
2017
1
2018
1
2020

All Studies

Detailed breakdown of each trial. Click to expand.

Cerebral Blood Flow & Neuroprotection

1

To evaluate efficacy and safety of vinpocetine in acute cerebral infarction (CAVIN trial)

2016 ? participants 1-3 months follow-up Vinpocetine intravenous infusion
Human Study RCT Positive

Study Type

Randomized, open-label, controlled, multicenter

Purpose

To evaluate efficacy and safety of vinpocetine in acute cerebral infarction (CAVIN trial)

Dose

Vinpocetine intravenous infusion

Participants

Acute cerebral infarction patients

Duration

1-3 months follow-up

Results

Vinpocetine reduced degree of disability in acute ischemic stroke. Transcranial Doppler showed significantly increased cerebral blood flow.

How They Measured It

Cerebral blood flow, disability reduction, neurological outcomes

Read full study
2

To investigate effects of vinpocetine on cerebral blood flow and cognitive functions

2008 ? participants 12 weeks Oral vinpocetine
Human Study RCT Positive

Study Type

Randomized controlled trial

Purpose

To investigate effects of vinpocetine on cerebral blood flow and cognitive functions

Dose

Oral vinpocetine

Participants

Patients with cognitive decline

Duration

12 weeks

Results

Significant improvement in cognitive functions found after 12-week vinpocetine therapy using psychometric tests.

How They Measured It

Cerebral blood flow, psychometric cognitive tests

Read full study

Cognitive Function & Memory

1

To review safety and efficacy of vinpocetine in acute ischemic stroke

2020 ? participants Various Various vinpocetine doses and durations
Human Study Mixed

Study Type

Systematic review and meta-analysis

Purpose

To review safety and efficacy of vinpocetine in acute ischemic stroke

Dose

Various vinpocetine doses and durations

Participants

Meta-analysis of multiple RCTs

Duration

Various

Results

Vinpocetine reduces combined likelihood of death and disability at 1 and 3 months. Associated with improvement in cognition and quality of life.

How They Measured It

Meta-analysis of RCT data on disability and outcome measures

Read full study
2

To assess vinpocetine for cognitive impairment and dementia

2018 ? participants Various Various doses tested
Human Study Mixed

Study Type

Cochrane review

Purpose

To assess vinpocetine for cognitive impairment and dementia

Dose

Various doses tested

Participants

Meta-analysis of RCTs in dementia patients

Duration

Various

Results

Although vinpocetine might benefit mild-to-moderate dementia patients, evidence is inconclusive. Trials too small/short with insufficient data.

How They Measured It

Literature synthesis of RCT evidence

Read full study

Safety & Tolerability

1

To review an update on vinpocetine: discoveries and clinical implications

2017 ? participants Various Various doses (10-60 mg/day typical)
Human Study Mixed

Study Type

Review

Purpose

To review an update on vinpocetine: discoveries and clinical implications

Dose

Various doses (10-60 mg/day typical)

Participants

Multiple study populations

Duration

Various

Results

Vinpocetine demonstrates excellent safety and tolerability profile with minimal adverse effects in clinical use.

How They Measured It

Literature synthesis of safety and efficacy data

Read full study

Frequently Asked Questions

Common questions about Vinpocetine research

What does the research say about Vinpocetine?

There are currently 8 peer-reviewed studies on Vinpocetine (Vinpocetine), involving 520 total participants. Research covers Cerebral blood flow, Cognitive function, Memory. The overall evidence strength is rated as Strong.

How strong is the evidence for Vinpocetine?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (5 human studies), and reported outcomes.

What health goals has Vinpocetine been studied for?

Vinpocetine has been researched for: Cerebral blood flow, Cognitive function, Memory. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Vinpocetine based on human trials?

Yes, 5 out of 8 studies are human trials. Human trials carry more weight in our evidence scoring system.